AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Feb 16, 2012
30016_dirs_2012-02-16_52a43853-72aa-41ce-bab2-6f671b432809.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-02-14
Reporting Person: AYERS JONATHAN W (Director, Chairman, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-14 | Common Stock | M | 1200 | — | Acquired | 328991 | Direct |
| 2012-02-14 | Common Stock | M | 1600 | — | Acquired | 330591 | Direct |
| 2012-02-14 | Common Stock | M | 1600 | — | Acquired | 332191 | Direct |
| 2012-02-14 | Common Stock | M | 1200 | — | Acquired | 333391 | Direct |
| 2012-02-14 | Common Stock | M | 1200 | — | Acquired | 334591 | Direct |
| 2012-02-14 | Common Stock | F | 3055 | $87.42 | Disposed | 331536 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-14 | Non-Qualified Stock Option (right to buy) | $87.42 | A | 58857 | Acquired | 2019-02-13 | Common Stock (58857) | Direct |
| 2012-02-14 | Incentive Stock Option (right to buy) | $87.42 | A | 1143 | Acquired | 2019-02-13 | Common Stock (1143) | Direct |
| 2012-02-14 | Restricted Stock Unit | $ | A | 6000 | Acquired | Common Stock (6000) | Direct | |
| 2012-02-14 | Restricted Stock Unit | $ | M | 1200 | Disposed | Common Stock (1200) | Direct | |
| 2012-02-14 | Restricted Stock Unit | $ | M | 1600 | Disposed | Common Stock (1600) | Direct | |
| 2012-02-14 | Restricted Stock Unit | $ | M | 1600 | Disposed | Common Stock (1600) | Direct | |
| 2012-02-14 | Restricted Stock Unit | $ | M | 1200 | Disposed | Common Stock (1200) | Direct | |
| 2012-02-14 | Restricted Stock Unit | $ | M | 1200 | Disposed | Common Stock (1200) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock becomes exercisable as to 12,000 shares on 02/14/2013, 02/14/2014, 02/14/2015 and 02/14/2016, and the remaining 10,857 shares on 02/14/2017.
F2: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2017) of the grant.
F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.
F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.
F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.
F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2008) of the date of grant.